Why the study?
Is serum hs-CRP associated with left ventricular hypertrophy in patients with lupus nephritis?
Is serum hs-CRP associated with left ventricular hypertrophy in patients with lupus nephritis?
Serum hs-CRP is independently associated with left ventricular mass index and may serve as a biomarker for left ventricular hypertrophy in patients with lupus nephritis.
hs-CRP was associated with LVH in lupus nephritis; hypothesis-generating and requires prospective validation before clinical use.
OBJECTIVE: To determine the prevalence of left ventricular hypertrophy (LVH) and its associated risk factors in lupus nephritis (LN) patients. METHODS: 287 LN patients (age: 38.54 ± 13.31, 262 female) were recruited. Echocardiography and serum high-sensitivity C-reactive protein (hs-CRP) were measured. Their relationship was evaluated by univariate correlation analysis and multivariate regression analysis. RESULTS: The prevalence of LVH in this cohort was 21.25% (n = 61). Serum hs-CRP level was significantly elevated in patients with LVH compared to those without (8.03 (3.22-30.95) versus 3.93 (1.48-9.48) mg/L, P < .01), and correlated with left ventricular mass index (LVMI) (r = 0.314, P = .001). Multivariate regression analysis further confirmed that hs-CRP was an independent risk factor (β = 0.338, P = .002) for LVH in patients with LN. CONCLUSIONS: Our findings demonstrated that serum hs-CRP level is independently correlated with LVMI and suggested that measurement of hs-CRP may provide important clinical information to investigate LVH in LN patients.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: